Education
About Us
Working with TipRanks
Follow Us
Dr. Reddy's Laboratories Ltd (RDY)
NYSE:RDY
Earnings Data
Report Date
Jul 23, 2025Before Open (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
0.22Last Year’s EPS
0.2Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlighted strong financial performance with record revenue and EBITDA, significant growth in the European market, progress in biosimilars, and sustainability accolades. However, there were challenges in the U.S. generics market, regulatory issues in Hyderabad, and a sequential decline in the India business.Company Guidance -
Q4 2025
Record Quarterly Revenue and EBITDA
Dr. Reddy's Laboratories achieved its highest ever quarterly revenue and EBITDA in Q3 FY '25, driven by a 16% year-on-year revenue growth to INR 8,359 crores (USD 977 million) and the inclusion of the Nicotine Replacement Therapy business.
Strong Growth in Europe
The European Generics business, including NRT, recorded USD 134 million in revenue, a 142% year-over-year increase. Excluding NRT, the growth was 22% YoY.
Significant Progress in Biosimilars
Dr. Reddy's secured marketing authorization for rituximab in the U.K. and filed denosumab in both the U.S. and Europe, marking progress in their biosimilars journey.
Sustainability and ESG Recognition
Dr. Reddy's achieved an ESG score of 79 out of 100, placing them fifth globally among pharma companies in the S&P Global CSA. They continue to be members of the DJSI World Index and have an upgraded MSCI ESG rating of A.
RDY Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
RDY Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 09, 2025 | $13.18 | $13.40 | +1.67% |
Jan 23, 2025 | $15.09 | $14.15 | -6.23% |
Nov 05, 2024 | $14.80 | $14.61 | -1.28% |
May 07, 2024 | $14.90 | $14.20 | -4.70% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Dr. Reddy's Laboratories Ltd (RDY) report earnings?
Dr. Reddy's Laboratories Ltd (RDY) is schdueled to report earning on Jul 23, 2025, Before Open (Confirmed).
What is Dr. Reddy's Laboratories Ltd (RDY) earnings time?
Dr. Reddy's Laboratories Ltd (RDY) earnings time is at Jul 23, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is RDY EPS forecast?
RDY EPS forecast for the fiscal quarter 2026 (Q1) is 0.22.